Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKD3 | O94806 | 1/20 | 0.37 |
| ▸ | PRKCG | P05129 | 1/20 | 0.37 |
| ▸ | PRKCB | P05771 | 1/20 | 0.37 |
| ▸ | PRKCA | P17252 | 1/20 | 0.37 |
| ▸ | PRKCH | P24723 | 1/20 | 0.37 |
| ▸ | PRKCI | P41743 | 1/20 | 0.37 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.37 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.37 |
| ▸ | PRKCZ | Q05513 | 1/20 | 0.37 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.37 |
| ▸ | PRKD1 | Q15139 | 1/20 | 0.37 |
| ▸ | LPAR1 | Q92633 | 5/20 | 0.36 |
| ▸ | LPAR3 | Q9UBY5 | 5/20 | 0.36 |
| ▸ | LPAR6 | P43657 | 3/20 | 0.36 |
| ▸ | LPAR4 | Q99677 | 3/20 | 0.36 |
| ▸ | LPAR5 | Q9H1C0 | 3/20 | 0.36 |
| ▸ | LPAR2 | Q9HBW0 | 3/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4547625 | 0.86 | PRKD3 (0.37) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL10028008 | 0.86 | PRKD3 (0.41) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL820179 | 0.86 | PRKD3 (0.41) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL13225891 | 0.86 | PRKD3 (0.41) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL12655009 | 0.83 | PRKD3 (0.34) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL51157 | 0.83 | — | — | |
| SCHEMBL14904902 | 0.79 | PRKD3 (0.41) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL14904899 | 0.79 | PRKD3 (0.41) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL4547611 | 0.79 | PRKD3 (0.41) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL19546092 | 0.77 | PRKD3 (0.36) | PRKD3PRKCGPRKCBPRKCAPRKCH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130210094-A1 | HETEROGENEOUS ENZYMATIC CATALYST, PROCESS FOR PREPARING SAME AND USE FOR CONTINUOUS FLOW ENZYMATIC CATALYSIS | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2013-08-15 | — | — | US | disclosed |
| US-20120108512-A1 | STABLE PHARMACEUTICAL COMPOSITIONS OF PEPTIDE DERIVATIZED USING AN OXIME LINKER | NOVO NORDISK HEALTH CARE AG (CH) | 2012-05-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120108512-A1 | STABLE PHARMACEUTICAL COMPOSITIONS OF PEPTIDE DERIVATIZED USING AN OXIME LINKER | PTMS, NGLY1, IAPP | PRKD3 3027/4885PRKCG 3835/4885PRKCB 4358/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.